Immunosuppressive therapy. 1.
作者信息
Skinner M D, Schwartz R S
出版信息
N Engl J Med. 1972 Aug 3;287(5):221-7. doi: 10.1056/NEJM197208032870504.
PMID:4556641
Abstract
摘要
相似文献
1
Immunosuppressive therapy. 1.免疫抑制疗法。1.
N Engl J Med. 1972 Aug 3;287(5):221-7. doi: 10.1056/NEJM197208032870504.
2
[Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].[免疫性疾病的长期治疗，特别提及免疫抑制剂的使用]
Dtsch Med Wochenschr. 1969 Nov 21;94(47):2444-9. doi: 10.1055/s-0028-1110464.
3
Immunosuppressive therapy.免疫抑制疗法。
Am J Med Sci. 1973 Feb;265(2):92-108.
4
[The immunosuppressive agents. 3. The immunosuppressive agents in hematology].[免疫抑制剂。3. 血液学中的免疫抑制剂]
Presse Med (1893). 1967 Jul 1;75(32):1653-5.
5
[Immunosuppressive long-term therapy of autoimmune diseases in hematology].[血液学中自身免疫性疾病的长期免疫抑制治疗]
Z Gesamte Inn Med. 1972 Jun 1;27(11):480-3.
6
[Drug immunosuppression].[药物免疫抑制]
Kinderarztl Prax. 1975 Jul;43(7):308-25.
7
[Treatment of autoimmune diseases].[自身免疫性疾病的治疗]
Schweiz Med Wochenschr. 1971 Oct 2;101(39):1393-9.
8
[Auto-immune diseases and immunodepressive therapy. II. Current clinical indications].[自身免疫性疾病与免疫抑制治疗。II. 当前的临床适应症]
Acta Clin Belg. 1974;29(6):413-23. doi: 10.1080/17843286.1974.11716963.
9
[Immunosuppressive therapy].[免疫抑制疗法]
Stud Cercet Med Interna. 1973;14(3):209-16.
10
Lymphocyte transformation tests in patients under treatment with immunosuppressive drugs.
Helv Med Acta. 1969 Nov;35(2):140-5.
引用本文的文献
1
Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.在克罗恩病患者使用传统硫嘌呤类药物失败后，替考拉宁的耐受性和药物存活率优于甲氨蝶呤。
J Crohns Colitis. 2022 Sep 8;16(9):1372-1379. doi: 10.1093/ecco-jcc/jjac044.
2
An Analysis of the Infections and Determination of Empiric Antibiotic Therapy in Cats and Dogs with Cancer-Associated Infections.癌症相关感染的猫和狗的感染分析及经验性抗生素治疗的确定
Antibiotics (Basel). 2021 Jun 11;10(6):700. doi: 10.3390/antibiotics10060700.
3
The treatment of disseminated vasculitis with methotrexate.甲氨蝶呤治疗弥漫性血管炎。
Inflammation. 1976 Jun;1(3):285-95. doi: 10.1007/BF00917868.
4
Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.成人自身免疫性溶血性贫血的诊断与治疗：临床综述
Wien Klin Wochenschr. 2008;120(5-6):136-51. doi: 10.1007/s00508-008-0945-1.
5
Use of methotrexate in older patients. A risk-benefit assessment.老年患者使用甲氨蝶呤。风险效益评估。
Drugs Aging. 1996 Dec;9(6):458-71. doi: 10.2165/00002512-199609060-00008.
6
Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics.
Eur J Clin Pharmacol. 1995;47(6):507-11. doi: 10.1007/BF00193703.
7
Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.类风湿关节炎疾病进程改善治疗研讨会：免疫抑制的视角
Ann Rheum Dis. 1982;41 Suppl 1(Suppl 1):1-60. doi: 10.1136/ard.41.suppl_1.1-a.
8
The effect of cyclophosphamide on the antibody response.环磷酰胺对抗体反应的影响。
Proc R Soc Med. 1973 Aug;66(8):808-10. doi: 10.1177/003591577306600838.
9
Long-term immunosuppressive therapy of ulcerative colitis. Continuation of a personal series.溃疡性结肠炎的长期免疫抑制治疗。个人系列病例的延续
Am J Dig Dis. 1973 Apr;18(4):317-22. doi: 10.1007/BF01070993.
10
Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.环磷酰胺对已建立的细胞介导免疫的抑制作用。淋巴细胞群体的定量与定性变化。
J Clin Invest. 1975 Jul;56(1):65-70. doi: 10.1172/JCI108080.
Zotero 插件